Immune Design Corp. — Form D/A

Immune Design Corp. of SEATTLE, WA, a company, filed a Form D amendment with the SEC on 2010-08-26. The offering totals $34.0M, of which $12.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (38)

Showing 25 of 38 people.

NameRoleLocation
Bruce CarterExecutive OfficerSeattle, WA
Thomas DubenskyExecutive OfficerSeattle, WA
Sammy FarahExecutive OfficerNew York, NY
Steven ReedDirectorMichigan CIty, IN
Steven ReedExecutive OfficerMichigan CIty, IN
Brian AtwoodDirectorSouth San Francisco, CA
David BaltimoreDirectorSan Diego, CA
James Paul RickeyExecutive OfficerSeattle, WA
Richard KlausnerDirectorSouth San Francisco, CA
PETER V SVENNILSONDirectorSAN FRANCISCO, CA
Paul T RickeyExecutive OfficerSeattle, WA
William T RingoDirectorSeattle, WA
Jan Henrik T ter MeulenExecutive OfficerSeattle, WA
Brian V AtwoodDirectorSeattle, WA
Alain V SchreiberDirectorSeattle, WA
Bruce V CarterDirectorSeattle, WA
Wayne R GombotzExecutive OfficerSeattle, WA
James T RickeyExecutive OfficerSeattle, WA
Ed V PenhoetDirectorSeattle, WA
Richard T KenneyExecutive OfficerSeattle, WA
Carlos V PayaDirectorSeattle, WA
Carlos V PayaExecutive OfficerSeattle, WA
Stephen R BradyExecutive OfficerSeattle, WA
David V BaltimoreDirectorSeattle, WA
Wayne Paul GombotzExecutive OfficerSeattle, WA

Other filings by this issuer (10)

FiledFormOfferingSold
2014-06-12D$18K$18K
2014-06-11D$10$10
2014-06-11D/A$11K$11K
2013-10-31D$57.8M$48.5M
2013-01-30D/A$34.0M$34.0M
2011-10-05D/A$34.0M$23.4M
2010-08-05D$32.0M$12.0M
2009-10-06D$11K$11K
2009-07-29D$14K$14K
2009-07-08D/A$18.0M$14.0M

More